The use of commercially available media to achieve high titer in early process development is discussed.
Hao Chen
Advertisement
Articles by Hao Chen
Advertisement
Latest Updated Articles
Rapid Early Process Development Enabled by Commercial Chemically Defined Media and MicrobioreactorsPublished: February 1st 2015 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
2
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
3
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
4
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
5
